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Tc     Crystallization temperature 
Tg     Glass transition temperature 
Tm     Melting temperature 
UV     Ultraviolet 
vvm Gas volume flow per unit of liquid volume per 
minute (volume per volume per minute) 
v/v     Volume per volume 
x     Biomass 
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xc     Crystallinity 
xm     Biomass at t = 0 
xm     Maximum biomass 
Xc     Degree of crystallinity 
w/v     Weight per volume 
wt%     Weight percentage 
wt% C     Weight percentage of carbon 
Yx/s     Yield coefficient of biomass over substrate 
Yp/s     Yield coefficient of product over substrate 
Yp/x     Yield coefficient of product over biomass 
ZnSO4·7H2O    Zinc sulphate heptahydrate 
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BIOSINTESIS SATU PERINGKAT POLI(3-HIDROKSIBUTIRAT-ko-4-
HIDROKSIBUTIRAT) MENGGUNAKAN Cupriavidus sp. USMAA1020 
MELALUI STRATEGI PENGKULTURAN SUBSTRAT CAMPURAN 
 
ABSTRAK 
Kopolimer poli(3-hidroksibutirat-ko-4-hidroksibutirat) [P(3HB-ko-4HB)] 
merupakan polihidroksialkanoat (PHA) yang penting dalam bidang biofarmaseutikal 
dan perubatan. Produktiviti kopolimer dengan komposisi 4HB yang tinggi sering 
dicapai melalui pengkulturan dua-peringkat tetapi ini menyukarkan dengan 
meningkatkan masa dan usaha pengendalian, dan risiko kontaminasi dalam proses 
penghasilan berskala besar. Kajian ini bertujuan untuk membangunkan strategi 
fermentasi satu-peringkat yang berkesan menggunakan strategi pengkulturan substrat 
campuran sebagai pengganti fermentasi dua-peringkat. Strategi ini menunjukkan 
kesan sinergi substrat campuran yang ketara terhadap pengumpulan P(3HB-ko-4HB) 
secara satu-peringkat dengan peningkatan kandungan dan kepekatan PHA sebanyak 
74% (b/b) dan 6.9 g/L masing-masing; dan komposisi monomer 4HB dari 7 mol% ke 
70 mol%. Ianya adalah selaras dengan eksperimen menggunakan karbon tunggal 
yang menunjukkan penghasilan PHA tertinggi sebanyak 57% (b/b), 3.1 g/L dan 48 
mol% 4HB. Manipulasi substrat campuran dan nisbah di dalam bioreaktor 
menunjukkan bahawa kebanyakan proses fermentasi telah menghasilkan kandungan 
PHA yang melebihi 50% (b/b), dengan satu siri kopolimer yang mengandungi 
komposisi monomer 4HB yang pelbagai dari 12 mol%  ke 55 mol%. Penghasilan 
PHA yang tinggi sebanyak 73% (b/b) telah diperolehi, dan seterusnya 
menyumbangkan kepekatan dan hasil PHA yang tinggi sebanyak 8.6 g/L dan 2.7 g/g. 
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Ciri-ciri kopolimer tersebut telah dipengaruhi oleh jenis substrat dan strategi 
pencampuran. Bioproses satu-peringkat yang dijalankan menepati dengan baik model 
logistik dan Luedeking-Piret (dan yang diubahsuai), dibuktikan dengan nilai R2 yang 
tinggi dari 0.9153 ke 0.9957. Penggunaan kedua-dua substrat dan penghasilan 
P(3HB-ko-4HB) adalah pada kadar yang tinggi pada fasa pertumbuhan eksponen 
bakteria, dicirikan oleh nilai pemalar pertumbuhan-berkait penggunaan substrat (γ) 
dan pengumpulan P(3HB-ko-4HB) (α) yang tinggi, masing-masing dari 0.0690 g/g 
ke 0.2863 g/g dan 0.0660 g/g ke 0.1886 g/g. Hal ini adalah selari dengan nilai 
pemalar pertumbuhan tak-berkait, δ dan β yang menunjukkan kadar penggunaan 
substrat dan penghasilan kopolimer yang rendah, masing-masing dari 3.9 × 10-5 g/g/h 
ke 0.0011 g/g/h dan 0.0092 g/g ke 0.0459 g/g pada fasa pertumbuhan pegun. 
Kopolimer P(3HB-ko-30 mol% 4HB) yang mempunyai berat molekul, 927 kDa dan 
pemanjangan-sehingga-putus tinggi dan 1637% telah dibiosintesiskan daripada 
0.56% (b/b C) 1,4-butanadiol dan 1,6-hexanadiol dengan nisbah 3:1. Peningkatan 
kadar goncangan dari 150 rpm ke 250 rpm telah menunjukkan peningkatan kadar 
penghasilan P(3HB-ko-4HB) yang efisien masing-masing dari 28 % (b/b) ke 63% 
(b/b) dan 3.1 g/L ke 6.5 g/L, yang meminimumkan penggunaan substrat terhadap 
pertumbuhan bakteria dari 8.0 g/L ke 3.8 g/L. Kepelbagaian kadar pengudaraan dari 
0.5 ke 1.0 vvm mengekalkan residu biojisim di antara 4.0 g/L dan 4.8 g/L tetapi 
diiringi dengan peningkatan kepekatan PHA dari 4.8 g/L ke 7.2 g/L. Pengkulturan 
substrat campuran telah terbukti sebagai strategi yang boleh meningkatkan 
produktiviti kopolimer, komposisi monomer 4HB dan sifat kopolimer dalam 
fermentasi secara satu-peringkat.  
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SINGLE-STAGE BIOSYNTHESIS OF POLY(3-HYDROXYBUTYRATE-co-4-
HYDROXYBUTYRATE) USING Cupriavidus sp. USMAA1020 VIA MIXED-
SUBSTRATE CULTIVATION STRATEGY 
 
ABSTRACT 
Poly(3-hydroxybutyrate-co-4-hydroxybutyrate) [P(3HB-co-4HB)] copolymer 
is polyhydroxyalkanoate (PHA) with biopharmaceutical and medical significance. 
Copolymer productivity with high 4HB monomer composition is usually achieved 
via two-stage cultivation but this reduces the ease of handling by increasing the time, 
effort and risk of contamination in large-scale production. This study aims to by-pass 
the two-stage fermentation by developing an efficient single-stage fermentation 
strategy using mixed-substrate cultivation. This strategy showed significant 
synergistic effect towards the single-stage production of P(3HB-co-4HB) with an 
enhanced PHA content and concentration up to 74 wt% and 6.9 g/L respectively; and 
4HB monomer composition from 7 mol% to 70 mol%. This is in relative to 
experimentation using sole carbon sources which recorded the highest PHA 
accumulation of 57 wt%, 3.1 g/L and 48 mol% 4HB. Manipulation of the substrate 
mixture and its mixing ratios in bioreactor revealed that most of the fermentations 
resulted in PHA content of more than 50 wt%, with a series of copolymers of 4HB 
monomer compositions ranged from 12 mol% to 55 mol%. A remarkably high PHA 
accumulation of 73 wt% was obtained, contributing to high PHA concentration and 
yield of 8.6 g/L and 2.7 g/g respectively. The copolymer characteristics were 
predominantly affected by the nature of substrates and the mixing strategies. The 
single-stage fermentation fit well to the logistic and Luedeking-Piret (and modified) 
models, evidenced by high adjusted R2 values of 0.9153 to 0.9957. Both substrates 
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utilization and P(3HB-co-4HB) accumulation were at higher rate during bacterial 
exponential growth phase, characterized by higher values of growth-associated 
substrate utilization (γ) and P(3HB-co-4HB) accumulation (α) constants of 0.0690 
g/g to 0.2863 g/g and 0.0660 g/g to 0.1886 g/g respectively. This is in relative to 
non-growth associated constants, δ and β which demonstrated lower substrates 
utilization and copolymer accumulation rate during stationary phase respectively at 
3.9 × 10-5 g/g/h to 0.0011 g/g/h and 0.0092 g/g to 0.0459 g/g. A P(3HB-co-30 mol% 
4HB) copolymer with high molecular weight and elongation at break values of 927 
kDa and 1637% was biosynthesized from 0.56 wt% C 1,4-butanediol and 1,6-
hexanediol at ratio of 3:1. An increase of agitation from 150 rpm to 250 rpm has 
resulted in increase efficiency of P(3HB-co-4HB) accumulation from 28 wt% to 63 
wt% and 3.1 g/L to 6.5 g/L respectively which concurrently minimized the utilization 
of substrates towards bacterial growth from 8.0 g/L to 3.8 g/L. Variation of aeration 
from 0.5 vvm to 1.0 vvm kept the residual biomass constant in between 4.0 g/L and 
4.8 g/L but accompanied with an increase of PHA concentration from 4.8 g/L to 7.2 
g/L. The mixed-substrate cultivation was proven to be promising strategy to enhance 
copolymer yield, 4HB accumulation and characteristics in single-stage fermentation.  
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CHAPTER 1: INTRODUCTION 
1.1 Research background 
Polyhydroxyalkanoates (PHAs) are group of biopolymers made up of diverse 
range of monomers. To date, over 150 monomer constituents have been identified as 
building blocks of PHAs (Gao et al., 2011; Urtuvia et al., 2014; Jia et al., 2016). Of 
all PHAs, poly(3-hydroxybutyrate-co-4-hydroxybutyrate) [P(3HB-co-4HB)] 
copolymer is known to be suitable absorbable biomaterial in medical and 
pharmaceutical applications. It can be specifically applied for wound healing, 
orthopedics, therapeutics, drug delivery, tissue engineering and etc (Koller et al., 
2007; Chee et al., 2008; Wu et al., 2009; Brigham and Sinskey, 2012; Luef et al., 
2015; Phong et al., 2016).  
There are few reasons directing the usage of the copolymer as high value 
medical product. Unlike other PHAs, this copolymer was found not only degraded by 
depolymerases, but also capable of hydrolyzation by lipases and esterases from both 
prokaryotes and eukaryotes (Doi et al., 1992; Saito et al., 1996; Li et al., 2010; Hsieh 
et al., 2009; Vigneswari et al., 2016). This is due to the absence of alkyl side chain as 
pendant group on 4HB monomers being attached to the copolymer chain (Mukai et 
al., 1993; Saito et al., 1996). The introduction of 4HB monomer results in 
copolymers with higher in vivo degradation rate than other PHAs (Loo and Sudesh, 
2007; Li et al., 2010). Besides, the degradation of P(3HB-co-4HB) releases 3-
hydroxybutyric acid and 4-hydroxybutyric acid which are natural metabolites 
presence in human bloodstream (Bessman and Fishbein, 1964; Lee, 1996a; Martin 
and Williams, 2003). This enhances the biocompatibility as the copolymer has the 
ability to tolerate inflammatory responses with tissue, without imposing detrimental 
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side effect on human body. In term of the material properties, the copolymer exhibits 
wide variety of mechanical strengths from highly crystalline plastic to elastomeric 
rubber-like material, upon combining both 3HB and 4HB monomer constituents at 
varying molar fractions (Doi et al., 1990; Saito et al., 1996; Loo and Sudesh, 2007; 
Cesário et al., 2014). This improves the potential of biomaterial applications since 
the resulting copolymers can be tailored to meet specific needs. P(3HB-co-4HB) 
copolymer is considered to be one of the most valuable biopolymer among the vast 
number of PHAs being synthesized by numerous microorganisms (Amirul et al., 
2008; Park and Kim, 2011). 
1.2 Problem statement 
P(3HB-co-4HB) is produced via fermentation process rather than chemical 
synthesis (Martin and Williams, 2003). To date, most of the fermentations targeting 
on this copolymer uses two- or three-stage cultivation in order to obtain high PHA 
productivity and copolymers with high 4HB monomer composition (Doi et al., 1988; 
Kunioka et al., 1989a; Doi et al., 1990; Nakamura et al., 1992; Saito et al., 1996; 
Choi et al., 1999; Mitomo et al., 2001; Kim et al., 2005; Lee et al., 2007; Amirul et 
al., 2008; Hsieh et al., 2009; Vigneswari et al., 2009 Rao et al., 2010a). This includes 
the production of poly(4-hydroxybutyrate) [P(4HB)] homopolymer as well (Saito 
and Doi, 1994; Saito et al., 1996; Choi et al., 1999). Obtaining copolymers with 
higher 4HB monomer composition is desirable as it is generally concluded that this 
would enhance the copolymer’s application as biomaterial in medical and bio-
pharmaceutical (Martin and Williams, 2003). However, multi-stages fermentation 
strategy is not feasible when it comes to industrial scale production. This bioprocess 
requires a minimum of two fermentation vessels which involves the use of nutrient-
rich medium for bacterial growth phase, followed by nitrogen-free medium for PHA 
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accumulation phase in separate vessels. This reduces the ease of handling, prone to 
the risk of contamination during inocula transfer and indirectly increases the 
operational cost and effort (Rahayu et al., 2008). Production of P(3HB-co-4HB) via 
single-stage cultivation is less frequently employed and usually returned with either 
low copolymer productivity and/or low 4HB monomer composition. For example, 
Park and Kim (2011) were able to produce high biomass of 10 g/L to 20 g/L but 
resulted in accumulation of low 4HB monomer composition of 6 mol% to 10 mol%. 
Kang et al. (1995) were able to produce P(3HB-co-4HB) with high 4HB monomer 
composition up to 83 mol% but with low PHA concentration of 0.4 g/L. In spite of 
this, single-stage cultivation still offers an advantage in industrial-wise for the 
production of P(3HB-co-4HB). 
To date, the production of this copolymer has not been extensively explored 
in bioreactor scale through single-stage fermentation. This is also true even for two-
stage fermentation process which normally resulted in production of homopolymer 
P(4HB) or copolymer P(3HB-co-4HB) with high 4HB monomer composition. Most 
of the two-stage fermentations were carried out in shake-flask fermentation (Renner 
et al., 1996; Saito et al., 1996; Choi et al., 1999; Mitomo et al., 2001; Lee et al., 
2004; Kim et al., 2005; Chai et al., 2009; Rao et al., 2010b; Vigneswari et al., 2010). 
Several recent studies have reported the copolymer production through single-stage 
fermentation in bioreactor but these did not return with copolymer of higher 
productivity and higher 4HB monomer composition (Park and Kim, 2011; 
Cavalheiro et al., 2012; Cesário et al., 2014). The copolymers produced have 4HB 
monomer compositions of less than 15 mol%.  
Overall, there are some limitations on the upstream biosynthesis of the 
copolymer. This will eventually reduce the feasibility of the copolymers to be 
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applied in healthcare application. In light of this, investigation and search for an 
efficient approach that will optimally produce the copolymer is significantly 
important.  
1.3 Objectives 
In the present study, the P(3HB-co-4HB) copolymer was biosynthesized by 
Cupriavidus sp. USMAA1020 isolated from Malaysian environment. The novelty of 
the work comes from the idea of relating the mixed-substrate cultivation strategy on 
the single-stage production of the P(3HB-co-4HB) copolymer. To the best of my 
knowledge, there are limited publications which discussed the effect of the strategy 
on P(3HB-co-4HB) production in details. It is hypothesized that substrate mixture 
strategy would overcome the limitation in single-stage cultivation, leading to the 
development of efficient bioprocess strategy for the copolymer production.   
The objectives of this study are: 
1. To evaluate the applicability of mixed-substrate cultivation in improving single-
stage production of P(3HB-co-4HB) through shake-flask scale fermentation. 
2. To produce P(3HB-co-4HB) copolymers from single-stage mixed-substrate 
cultivation in controlled bioreactor system.  
3. To study the production kinetics and characteristics of P(3HB-co-4HB) 
biosynthesized by Cupriavidus sp. USMAA1020 in single-stage mixed-substrate 
cultivation system.  
4. To investigate the parameters affecting the upscaling process of P(3HB-co-4HB) 
from lab to pilot scale fermentation.  
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CHAPTER 2: LITERATURE REVIEW 
2.1 Polyhydroxyalkanoates (PHAs): The next generation bioplastics 
2.1.1 PHAs in general   
Polyhydroxyalkanoates (PHAs) are a group of natural biopolymer consisting 
of a repeated chain of hydroxyalkanoates (HAs) monomer. These biopolymers are 
synthesized by a wide variety of microorganisms under stress conditions whereby the 
surrounding environments are limited of nutrients such as nitrogen, magnesium, 
phosphorus or oxygen but sufficient with carbon sources (Anderson and Dawes, 
1990; Liu et al., 2016).  
PHAs are identified as one of bacterial storage components analogous to 
starch and glycogen (Dawes and Senior, 1973; Olukoshi and Packter, 1994; Sudesh 
et al., 2000). PHAs are lipoidic and belong to one of the four principal classes of the 
storage polymers namely lipids, carbohydrates, polyphosphates and nitrogen reserve 
compounds found in microorganisms (Dawes, 1985). Under the restricted microbial 
growth conditions, the carbon sources are converted to PHAs, which serves as 
intracellular carbon and energy storage compounds. PHAs exhibit high degree of 
polymerization by the action of PHA synthase, with the resulting molecular weight 
up to several million Daltons (Anderson and Dawes, 1990; Valappil et al., 2007). 
PHAs exist in the form of discrete inclusion bodies, typically 0.2 µm to 0.5 
µm in diameter; and localized in a mobile amorphous state within the cytoplasm of 
the cells (Dawes and Senior, 1973; Lee, 1996a; Sudesh et al., 2000). These granules 
are highly refractive and can be clearly visualized under phase contrast and electron 
microscopic observation (Dawes and Senior, 1973; Lee, 1996a; Sudesh et al., 2000). 
PHAs are water-insoluble. This makes PHA an excellent energy reserve material 
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since it does not contribute to any significant increase in osmotic pressure within the 
bacterial cytoplasm, even in a high quantity of PHAs (Loo and Sudesh, 2007). As the 
physiological fitness of the cells is not affected, this would prevent the leakage of 
valuable compounds out of the cells which in turn securing the stored nutrients at 
low maintenance cost (Peters and Rehm, 2005; Rehm, 2006; Verlinden, 2007).  
PHAs are synthesized by various bacterial species from eubacteria and 
archeabacteria with a total of more than 90 generas (Zinn et al., 2001; Kessler et al., 
2001; Rehm, 2006). This includes numerous Gram-positive and Gram-negative 
bacteria in which the former is prominently represented by Bacillus sp., Streptomyces 
sp., Rhodococcus sp., Clostridium sp., Staphylococcus sp., Corynebacterium sp., and 
Nocardia sp.; whereas the latter is notably denoted to Cupriavidus sp., Pseudomonas 
sp., Methylobacterium sp., Azotobacter sp., Burkholderia sp. and recombinant 
Escherichia coli (Lee, 1996a; Valappil et al., 2007; Liu et al., 2016).  
Among all these, the Gram-negative Cupriavidus necator (formerly Ralstonia 
eutropha, Alcaligenes eutrophus or Waustersia eutropha) is the representative of 
PHA producers and extensively studied in PHA research (Jendrossek, 2009; 
Tanadchangsaeng and Yu, 2012). This is because the bacterium, of strictly 
respiratory and facultative chemolithoautotrophic is able to utilize a diverse range of 
carbon sources from simple, defined to complex and inexpensive for growth and 
PHA biosynthesis (Kim et al., 1994; Sugimoto et al., 1999; Valappil et al., 2007;  
Ashby et al., 2011). Besides, the bacterium can accumulate high quantities of PHA 
up to 90 wt% of the biomass under appropriate nutrient depleted conditions 
(Jendrossek and Handrick, 2002; Khanna and Srivastava, 2005; Chen, 2009; 
Tanadchangsaeng and Yu, 2012).  
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At present, PHA producing microorganisms are found in either natural or 
engineered ecosystems such as in soil, marine, wastewater treatment plant, salt marsh 
and activated sludge process (Liu et al., 2016). The production of PHAs is not 
feasible via chemical synthesis but through in vivo accumulation by microorganism 
itself as processing factory (Valappil et al., 2007; Wang et al., 2014). Therefore, 
industrial scale production of successfully commercialized PHAs has usually been 
performed using enzyme and bioprocess engineering approach (Liu et al., 2016).  
Among the various biodegradable polymers, PHAs are excellent substitutes 
for petroleum-based synthetic plastics because they exhibit plastic-like feature in 
term of the physical and thermal properties. They are water resistance, oxygen 
impermeable and piezoelectric thermoplastics and/or elastomers (Valappil et al., 
2007; Keshavarz and Roy, 2010). Unlike conventional plastics, PHAs are known and 
recognized to be the only waterproof thermoplastics that are completely 
biodegradable in terrestrial and aquatic ecosystems by microorganisms (Philip and 
Roy, 2007). These polymers are degraded into harmless by-products, releasing 
carbon dioxide and water under aerobic conditions; methane and water under 
anaerobic conditions (Jendrossek and Handrick, 2002; Lim et al., 2005; Sridewi et 
al., 2006; Chanprateep, 2010). Without releasing any toxic waste, this resolves the 
issue of toxicity caused by the accumulation of non-degradable plastic waste.  
In addition, PHAs are completely being biosynthesized form renewable 
resources. This resolves the issue of over dependence on synthetic plastics which 
uses fossil fuels that are facing depletion as raw materials (Zinn et al., 2001; 
Steinbüchel, 2005; Chanprateep, 2010). PHAs have also caught attention due to their 
biocompatibility. They are immunologically inert which is promising in fabricating 
high-value medically related products.  
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PHAs are group of biopolymers made up of a diverse range of monomers. 
Depending on the substrate specificity of PHA synthase of the particular strain, 
various homopolymers, copolymers, terpolymers, blocks and blends PHAs could be 
synthesized. To date, there are more than 150 monomer constituents found to be 
produced by more than 300 microorganisms. The structural diversity of the 
monomers and compositions has resulted in PHAs with a wide range of physical and 
thermal characteristics. This has opened up to various opportunities for exploitation 
as there are many possibilities yet to be discovered in various applications. Figure 2.1 
shows the general chemical structure of various PHAs.  
Owing to the renewable, eco-friendly and the diversification of the material 
properties, PHAs are therefore can be applied into various sectors from disposable 
goods packaging, agriculture, aquacultural, to medical and biopharmaceutical 
industries (Chen and Wu, 2005; Tanadchangsaeng and Yu, 2012). PHAs are 
envisioned to be one of the next generation materials which will return lots of 
benefits to mankind and the world.  
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n = 1 R = hydrogen Poly(3-hydroxypropionate) 
 R = methyl Poly(3-hydroxybutyrate) 
 R = ethyl Poly(3-hydroxyvalerate) 
 R = propyl Poly(3-hydroxyhexanoate) 
 R = pentyl Poly(3-hydroxyoctanoate) 
 R = nonyl Poly(3-hydroxydodecanoate) 
n = 2 R = hydrogen Poly(4-hydroxybutyrate) 
 R = methyl Poly(4-hydroxyvalerate) 
n = 3 R = hydrogen Poly(5-hydroxyvalerate) 
 R = methyl Poly(5-hydroxyhexanoate) 
n = 4 R = hexyl Poly(5-hydroxydodecanoate) 
  
Figure 2.1: General structure of poly(3-hydroxyalkanoates) in which R refers to the 
length of side chain and n refers to size of alkyl group. PHAs are made up of carbon, 
hydrogen and oxygen atoms (Lee, 1996b) 
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2.1.2 History and development of PHAs 
PHAs have gone through for almost a century since they have been 
discovered (Keshavarz and Roy, 2010). Although the commercialization of PHAs 
have still returned in limited success, tremendous efforts have been carried out which 
expands the fundamentals of the microbial physiology in PHA biosyntheses, leading 
to the established manipulation of the production through multi-level omics (Chen, 
2009). According to Sudesh et al. (2000), the science and technology development of 
PHAs is significantly marked by three stages: discovery of P(3HB), identification of 
various hydroxyalkanoate monomers other than 3HB and manipulation of PHA 
biosynthesis genes. Along this timeline, the development is also closely related to the 
establishment and the improvement of PHA quantification method.  
The presence of lucent granules in bacterial cytoplasm was first reported by 
Beijerinck in 1888 (Amara and Moawad, 2011; Tanadchangsaeng, 2014). However, 
the composition of PHA was only characterized at the mid of 1920s, by a French 
microbiologist, Maurice Lemoigne who identified the inclusion bodies found in 
Bacillus megaterium as poly(3-hydroxybutyrate) [P(3HB)] (Anderson and Dawes, 
1990). By 1950s, accumulated studies from genus Bacillus suggested that P(3HB) 
functions as intracellular carbon and energy reserve. Dawes and Senior (1973) later 
on reviewed the physiological roles and concluded that the function of P(3HB) is 
analogous to starch and glycogen which are well known bacterial storage materials. 
Lemoigne was also the first who reported the analytical method for P(3HB). 
This has been performed via long processes including extraction, purification, 
saponification and distillation. These processes resulted in volatile and non-volatile 
fractions which both contains the polymer respectively in different forms, trans-2-
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butenoic acid (dehydrated 3-hydroxybutyric acid) and 3-hydroxybutyric acid. The 
compounds were weighed and represented as accurate amount of P(3HB) found in 
the bacterial cells.  
Lemoigne’s method was accurate but requires large biomass quantity and the 
whole process was time-consuming. To overcome this, various improvements have 
been carried out such as using spectrophotomeric method by Williamson and 
Wilkinson (1958), Slepecky and Law (1960) and Law and Slepecky (1961); glass 
fibre disk assay method by Ward and Dawes (1973) which permits faster and 
handling of smaller samples. Karr et al. (1983) and Hesselmann (1999) developed 
the P(3HB) quantification using ion exchange high-performance liquid 
chromatography (HPLC) and UV measurement.  
The 3-hydroxybutyrate (3HB) was the only known hydroxyalkanoate (HA) to 
be the building block of this polymer storage until 1970s. Wallen and Rohwedder 
(1974) discovered the presence of HAs other than 3HB in the chloroform extracts of 
activated sewage sludge. Analysis using nuclear magnetic resonance (NMR) 
revealed the presence of longer hydroxy fatty acids meanwhile the subsequent 
analysis by gas chromatography-mass spectroscopy (GC-MS) confirmed the 
presence of 3-hydroxyvalerate (3HV) and 3-hydroxyhexanoate (3HHx). Findlay and 
White (1983) detected that at least 11 HAs with 3HB and 3HV being major 
constituents in the polymer extracted from marine sendiments whereas 3HB, 3-
hydroxyheptanoate (3HHp) and 3-hydroxyoctanoate (3HO) were found in the 
polymer extracted from the monocultures of Bacillus megaterium. Odham et al. 
(1986) reported the presence of 3HB, 3HHx, and 3HO from activated sewage sludge. 
de smet et al. (1983) and Lageveen et al. (1988) significantly reported the 
accumulation of 3HO and 3HHx without 3HB from Pseudomonas oleovorans, when 
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grown on n-octane. The PHA quantification method has also come to its major 
advancement to this end. The method which consists of acidic based extraction, 
hydrolysis and methylation developed by Braunegg et al. (1978) provides accurate 
and more reproducible analytical measurement. The quantification method using gas 
chromatography (GC) was applied and adapted widely by many authors. 
The identification of other HA units marks a significant impact in PHA 
research, development and commercialization. This is due to the fact that 
homopolymer P(3HB) is brittle that limited the application as a substitute for 
synthetic plastic. Therefore, incorporation of foreign HA units into the P(3HB) 
polymer chain could enhance the overall material properties which extends the 
material applications.  
In early 1960s, PHA received its commercial attention by W.R. Grace & Co. 
(U.S.A) which patented the fermentation process of P(3HB) and its fabrication into 
absorbable prosthetic devices. However, the industrial scale exploitation of P(3HB) 
are remained inactive. Following the petroleum crisis in 1970s, the demand of 
searching alternatives for plastic industry has boosted. The Imperial Chemical 
Industries, ICI from United Kingdom (currently known as Zeneca Bio Products) has 
initiated the production of 70 wt% P(3HB) from Acaligenes latus. Besides, P(3HB-
co-3HV) copolymer was also produced and marketed under the trademark 
BIOPOL® by the same company. Monsanto, a splitting of ICI has later acquired the 
BIOPOL® and produces various range of P(3HB-co-3HV) copolymers in April 
1996. After two years, Metabolix Inc. obtained license from Monsanto and launched 
a company named Tepha Inc. which developed the medical devices using PHAs 
(Braunegg et al., 1998; Philip and Roy, 2007). Biotechnologische 
Forchungsgesellschaft is another company in Austria that has also developed the 
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pilot scale production of P(3HB) in 1990 (Hänggi, 1990; Hrabak, 1992; Kessler et 
al., 2001). The process which used sucrose as sole carbon source would able to 
accumulate the homopolymer up to 80% of cell dry weight. A biomass density of 60 
g/L was achieved but the production process stopped in 1993 (Kessler et al., 2001).  
The revolution of molecular biology approach in life science research has 
encouraged the understanding of PHA biosynthesis both at genetic and enzymatic 
level. By 1980s, genes that are responsible for PHA biosynthesis were successfully 
cloned from Ralstonia eutropha into Escherichia coli. Ralstonia eutropha was 
extensively studied as model for PHA biosynthesis and this revealed three important 
enzymes responsible in producing P(3HB) from acetyl-CoA. Up to year 2003, there 
was about 60 PHA synthase structural genes were cloned and sequenced from 
various eubacteria (Steinbüchel and Lutke-Eversloh, 2003; Kadouri et al., 2005).  
Generally, the development of PHAs can be categorized into upstream and 
downstream processing in which the former involves the biosynthesis of PHAs and 
the latter involves the characterization and application of PHAs as presented at 
Figure 2.2. The upstream processing of PHAs includes the isolation of 
microorganisms, screening and optimization, genetic modification and biosynthesis 
at various fermentation scales; meanwhile the downstream processing of PHAs 
covers the recovery and purification of the biopolymers, degradation, quantification, 
characterization as well as the application of PHAs.  
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Figure 2.2: The major pipelines in upstream and downstream processing of PHAs 
(Amirul et al., 2015) 
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2.1.3 Classification and properties of PHAs  
PHAs can be categorized based on its monomeric units. PHAs with three 
carbons (C3) to five carbons (C5) monomers are classified as short-chain-length 
(SCL-). PHAs with the range from C6 to C14 are classified as medium-chain-length 
(MCL).  
SCL-PHAs are stiff, brittle and crystalline materials that contains methyl or 
ethyl group as small side chains (Verlinden et al., 2007). Cupriavidus necator is one 
of the bacteria that produces SCL-PHAs (Matsusaki et al., 1998). Homopolymer 
P(3HB) is a typical example of SCL-PHA. It possesses high tensile strength that is 
comparable to commodity plastic such as polypropylene, but with a low elongation at 
break (Anderson and Dawes, 1990; Khanna and Srivastava, 2005). P(3HB) is rigid 
and brittle with low elasticity. This is due to its perfect stereoregularity which 
acquires detrimental aging process at ambient temperatures (de Koning and Lemstra, 
1993). It is highly crystalline which consists of large spherulites and possesses post-
crystallization behaviours. As a result, formation of the irregular pores on the surface 
limits the flexibility of amorphous polymer chain (Shishatskaya and Volova, 2004; 
Wen et al., 2012; Hong et al., 2011). The homopolymer exhibits high melting 
temperature at 170°C to 180°C. As a whole, this homopolymer is difficult to process 
and therefore unfavourable to be applied for industrial use.  
Even though P(3HB) is the most studied and well-characterized PHA, it 
should be noted that its characteristics do not represent the overall material properties 
of SCL-PHAs. By incorporating other hydroxyalkanoate units into the P(3HB) 
macromolecular chain, this will result in enhanced material properties following the 
disturbed and reduced crystal lattice arrangement of P(3HB) (Doi, 1995). This is 
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mainly accomplished by the addition of carbon precursors as co-substrate during the 
upstream biosynthesis process, which subsequently copolymerizes 3-
hydroxybutyrate and other monomers. The PHAs with improved material properties 
such as P(3HB-co-3HV), P(3HB-co-4HB), P(3HB-co-4HV), P(3HB-co-3HV-co-
4HB) are some of the known examples of SCL-PHAs.  
The discovery of the first MCL-PHA was dated on 1983, in which a polyester 
containing mainly of 3-hydroxyoctanoic acid from an axenic culture of Pseudomonas 
oleovorans (de smet et al., 1983; Koller et al., 2013). It was later found out that most 
of the bacteria from genus Pseudomonas (belong to rRNA-homology-group I) are 
capable to synthesize MCL-PHA, with only a few exceptions (Steinbüchel and 
Lutke-Eversloh, 2003). Typical MCL-PHAs includes P(3HHx-co-3HO-co-3HD) and 
P(3HHx-co-3HO-co-3HD-co-3HDD). These polymers are generally elastomeric and 
semi crystalline, which possesses low tensile strength and high elongation to break. 
In term of thermal properties, MCL-PHAs exhibits lower glass transition temperature, 
lower degree of crystallinity and broader melting range as compared to SCL-PHAs. 
Apart from that, these polymers also possess lower molar mass due to a low degree 
of polymerization (Koller et al., 2013). Table 2.1 shows general difference in 
between SCL-PHAs and MCL-PHAs.  
Since SCL-PHAs are stiff and brittle whereas MCL-PHAs are more 
elastomeric and flexible, incorporation of both SCL- and MCL- monomers will result 
in a SCL- MCL- copolymer which possesses the properties in between two states. 
The resulting polymer has superior properties as compared to either SCL- or MCL-
PHAs. According to Chen (2009), SCL-MCL-PHAs are ideal in advancing the on-
going development in various applications since they exhibit flexible mechanical 
properties. An attempt in producing this combination of copolymers started since 
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1988 by Brandl et al. (1989) who studied the ability of Rhodospirillum rubrum, a 
phototrophic bacterium to produce various kinds of PHAs. Among all the SCL-
MCL-PHAs produced, P(3HB-co-3HHx) is one of the successful polymer in this 
category been produced up to an industrial scale (Chen, 2009). P(3HB-co-3HV-co-
3HHx) terpolymer is another SCL-MCL-PHA which has returned novel and 
attractive properties to be employed in various application (Bhubalan et al., 2008). 
Pocter & Gamble has also trademarked SCL-MCL-PHA copolymers as NodaxTM 
which comprising of C4 and C6-C12 monomers (Bugnicour et al., 2014). 
 
Table 2.1: General differences of SCL-PHAs and MCL-PHAs (Koller et al., 2013; 
Amirul et al., 2015) 
 
SCL-PHAs Properties MCL-PHAs 
Around 0 °C Glass transition 
temperature (Tg) 
Around -40 °C 
Up to 70% Degree of crystallinity (Xc) Not more than 40 % 
Higher, up to 180 °C Melting point (Tm) Broad range of melting 
temperature 
Higher Molar mass Lower 
Higher Polydispersity (PDI) Lower 
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2.1.4 Biosynthesis of PHAs  
Since the first discovered PHA, P(3HB) was found to play significant role as 
carbon and energy source during imbalanced growth conditions, this has led to a 
remarkable interest in the metabolic pathways and regulatory metabolism of the PHA 
biosynthesis. The biosynthesis and utilization of PHAs are mediated by important 
enzymes such as PHA synthases (PhaC) and PHA depolymerases (PhaZ). PHA 
synthase is among the key enzyme that exclusively involved in PHA accumulation 
since it polymerizes the β-hydroxyalkanoyl-CoAs into poly-β-hydroxyalkanoate 
(Kadouri et al., 2005). PHA synthases are localized onto the surface of PHA granules 
together with phasins (PhaP)/regulator (PhaR) system which also involves in 
promoting PHA accumulation (York et al., 2002).  
Bacterial PHA synthases can be classified into Class I, Class II, Class III and 
Class IV PHA synthases in according to the subunit composition (either only PhaC, 
or PhaC with PhaE) and the substrate specificity (resulting in either SCL-PHAs or 
MCL-PHAs). Class I PHA synthases are known as SCL-PHA synthases, composed 
one type of subunit and use C3-C5 monomers as substrates; the MCL-PHA synthases 
are Class II synthases which also composed of one type of subunit but using C6-C14 
as substrates; meanwhile Class III PHA synthases uses C3-C5 substrates and 
composed of two different subunits. The three classes of the PHA synthases are 
generally represented by Ralstonia eutropha (Cupriavidus spp.), Pseudomonas 
aeruginosa (Pseudomonas spp.) and Allochromatium vinosum respectively 
(Stainbuchel and Lutke-Eversloh, 2003; Kadouri et al., 2005; Philip and Roy, 2007; 
Hyakutake et al., 2014; Ushimaru et al., 2014). Tsuge et al. (2015) highlighted the 
recent investigation of newest classification of PHA systhases. The class IV 
synthases composed of PhaC and PhaR subunit and are prevalent among 
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microorganism from Bacillus genus such as Bacillus megatarium and Bacillus 
cereus.  
The biosynthesis of P(3HB) is the best known PHA biosynthetic pathway. 
This SCL-PHA involves a three-step enzymatic reaction. In this pathway, β-
kethiolase (PhaA) catalyzes the formation of acetoacetyl-CoA from two acetyl-CoAs 
via condensation reaction. This is followed by the action of acetoacetyl-CoA 
reductase (PhaB) which reduces acetoacetyl-CoA to 3-hydroxybutyryl-CoA by 
NADH. Finally, PHA synthase (PhaC) polymerizes the 3-hydroxybutyryl-CoA to 
form P(3HB) via esterification reaction and release coenzyme-A. P(3HB) 
biosynthesis is regulated by intracellular concentration of acetyl-CoA and 3-
kethiolase. During balanced growth conditions, acetyl-CoAs are channeled towards 
tricarboxylic (TCA cycle). This releases a high amount of free coenzyme A which 
inhibits the activity of 3-kethiolase. When the growth is limited, the level of NADH 
and acetyl-CoA increases. Thus, the concentration of free coenzyme A reduced. This 
promote the activity of 3-kethiolase which stimulates P(3HB) biosynthesis (Zinn et 
al., 2001; Loo and Sudesh, 2007; Verlinden et al., 2007). Figure 2.3 shows the 
metabolic pathway of P(3HB) biosynthesis.  
The biosynthesis of SCL-PHAs other than P(3HB) occurs by feeding the 
structurally related precursor substrates to the microorganism. The production of 
these PHAs depends on the metabolism level required to convert the substrate 
precursors into corresponding hydroxyacly-CoA thioesters, as well as the broad 
substrate range of the PHA synthases (Steinbüchel and Valentin, 1995; Steinbüchel 
and Fuchtenbusch, 1998). For example, P(3HB-co-3HV) copolymer can be produced 
in most P(3HB) accumulating strain by feeding substrates such as pentanol, 
propionic acid, and valeric acid with odd number of carbon atoms. These substrates  
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Figure 2.3: Metabolic pathway of P(3HB) synthesis (Anderson and Dawes, 1990) 
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